Effect of aggressive daunomycin therapy on survival in acute promyelocytic leukemia.

Head, D; Kopecky, K J; Weick, J; Files, J C; Ryan, D; Foucar, K; Montiel, M; Bickers, J; Fishleder, A; Miller, M

Head, D; Kopecky, K J; Weick, J; Files, J C; Ryan, D; Foucar, K; Montiel, M; Bickers, J; Fishleder, A; Miller, M.

Affiliation

Head D; St Jude Children's Research Hospital, Memphis, TN, USA.

Blood ; 86(5): 1717-28, 1995 Sep 01.

Article in En | MEDLINE | ID: mdl-7655004

Subject(s)

Antineoplastic Agents/therapeutic use; Leukemia, Promyelocytic, Acute/drug therapy; Adolescent; Adult; Aged; Cytarabine/therapeutic use; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Leukemia, Promyelocytic, Acute/mortality; Leukemia, Promyelocytic, Acute/radiotherapy; Male; Middle Aged; Remission Induction; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome; Whole-Body Irradiation

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Promyelocytic, Acute / Antineoplastic Agents Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 1995 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links